Social inequalities in male mortality amenable to medical intervention in British Columbia

E Wood1, A M Sallar, M T Schechter

  • 1British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Insights

Men in lower social classes in British Columbia experienced higher mortality rates from preventable causes of death. This disparity was evident across various socioeconomic factors, highlighting a significant health inequity.

Area of Science:

  • Public Health
  • Epidemiology
  • Sociology

Background:

  • Social class and socioeconomic status significantly impact health outcomes.
  • Mortality amenable to medical intervention reflects healthcare access and quality disparities.

Purpose of the Study:

  • To investigate mortality rates from medically amenable causes among different social classes and socioeconomic groups of males in British Columbia.
  • To identify specific causes of death contributing to social disparities in health.

Main Methods:

  • Utilized 20% samples of occupational data from Canadian censuses (1981, 1986, 1991).
  • Classified individuals into five social class levels using an adapted UK Registrar General's Social Class Scale.
  • Employed the Blishen Index for three levels of socioeconomic analysis.
  • Calculated and standardized death rates for amenable causes.

Main Results:

  • Higher mortality rates from medically amenable causes were observed in lower social and socioeconomic classes compared to upper classes.
  • This mortality gradient persisted across various measures of social class, education, occupation, and income.
  • The most pronounced disparities were seen in deaths from hypertensive heart disease, tuberculosis, asthma, pneumonia, and bronchitis.

Conclusions:

  • Significant social class disparities exist in mortality from preventable causes among British Columbian males.
  • Targeted interventions to improve survival from specific conditions (e.g., cardiovascular, respiratory, infectious diseases) in lower social classes are crucial.
  • Addressing these disparities can help amend the social class gradient in health outcomes.

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...